rxstat › Shortages › Rubella Virus Live Attenuated Measles Mumps

Rubella Virus Live Attenuated Measles Mumps (M-M-R Ii) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Rubella Virus Live Attenuated Measles Mumps has no current shortage reported in Canada. It has been in shortage before; the history is below.

A vaccine used to protect against measles, mumps, and rubella.

Products affected

0 / 1

Reports on file

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Avoided

M-M-R II

1000CCID50 1000CCID50 5000CCID50 · POWDER FOR SOLUTION · MERCK CANADA INC

DIN 00466085 · ended Jan 12, 2025 · Demand increase for the drug.

Resolved

M-M-R II

1000UNIT 5000UNIT 1000UNIT · POWDER FOR SOLUTION · MERCK CANADA INC

DIN 00466085 · ended May 14, 2024 · Demand increase for the drug.

Resolved

M-M-R II

5000UNIT 1000UNIT 1000UNIT · POWDER FOR SOLUTION · MERCK CANADA INC

DIN 00466085 · ended Mar 20, 2020 · Delay in shipping of the drug.

Resolved

M-M-R II

5000UNIT 1000UNIT 1000UNIT · POWDER FOR SOLUTION · MERCK CANADA INC

DIN 00466085 · ended Jul 8, 2019 · Demand increase for the drug.

Resolved

M-M-R II

5000UNIT 1000UNIT 1000UNIT · POWDER FOR SOLUTION · MERCK CANADA INC

DIN 00466085 · ended May 31, 2019 · Demand increase for the drug.

Resolved

M-M-R II

5000UNIT 1000UNIT 1000UNIT · POWDER FOR SOLUTION · MERCK CANADA INC

DIN 00466085 · ended Oct 2, 2017 · Delay in shipping of the drug.

Resolved

M-M-R II

0.5 mL dose after reconstitution Measles: ≥1000 CCID50 Mumps: ≥5000 CCID50 Rubella: ≥1000 CCID50 · Powder For Solution · MERCK CANADA INC

DIN 00466085 · ended May 12, 2017 · Requirements related to complying with good manufacturing practices.

What's happening

There are no active shortage reports for Rubella Virus Live Attenuated Measles Mumps. Health Canada has 7 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Rubella Virus Live Attenuated Measles Mumps is classified under “VIRAL VACCINES” (ATC J07BD).

Recent changes

No changes recorded yet.

Common questions

What is Rubella Virus Live Attenuated Measles Mumps used for?

A vaccine used to protect against measles, mumps, and rubella.

When will Rubella Virus Live Attenuated Measles Mumps be back in stock in Canada?

Rubella Virus Live Attenuated Measles Mumps has no active shortage; supply is normal per Health Canada reports.

Why is Rubella Virus Live Attenuated Measles Mumps in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (viral vaccines)

Twinrix Junior (Hepatitis B Surface Antigen A Virus / Inactivated) Partial shortage 1 of 2 reported products affected Priorix-Tetra (Mumps Virus Live Attenuated Measles Varicella-zoster Rubella) Shortage anticipated 0 of 1 reported products affected *sarscov2 S-protein Mrna / 5'[m27 / 3'-ogppp (Comirnaty) No current shortage Chikungunya Virus Live-attenuated (Ixchiq) No current shortage Haemagglutinin-strain A B (Flulaval Tetra) No current shortage Hepatitis A Virus / Inactivated (Havrix) No current shortage

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.